C4 Therapeutics CCCC
NASDAQ CCCC
$3.13 +0.02 (+0.48%)
At close: Sep 29, 2026 · 4:00 PM EDT

C4 Therapeutics (CCCC) Operating Expenses (2019 - 2026)

Updated

C4 Therapeutics' Operating Expenses was $33.06 million in Q2 2026, down 5.4% from $34.96 million a year earlier and down 2.6% from the prior quarter.

Analysis

C4 Therapeutics (CCCC) Operating Expenses (2019 - 2026) Analysis & Trends

On a trailing twelve-month basis, C4 Therapeutics' Operating Expenses was $146.8 million through Jun 30, 2026, down 7.0% year-over-year; for FY2025, it came in at $151.17 million, down 2.6% from FY2024.

  • Operating Expenses has now declined for three consecutive years, though with a five-year compound annual growth rate of 10.1% (FY2020 to FY2025).
  • In earlier years, Operating Expenses was $155.2 million in FY2024 (-2.9%), $159.79 million in FY2023 (-0.5%), $160.63 million in FY2022 (+25.6%) and $127.92 million in FY2021 (+36.6%).
  • The Q2 2026 figure marks the lowest quarterly Operating Expenses since Q3 2021.
  • Compared with a year earlier, Operating Expenses has declined for three straight quarters, with an average decline of 0.3% over the last eight quarters.
  • The best year-over-year quarter for Operating Expenses over five years was Q1 2022 (growth of 39.7%); the worst was Q4 2025 (a decline of 20.3%).
  • Per Business Quant data, CCCC's Operating Expenses in the three quarters before Q2 2026 was $33.94 million (Q1 2026), $34.16 million (Q4 2025) and $45.64 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 10.12 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 10.56 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -9.70 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 18.20 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 2.09 Bn
10 C4 Therapeutics 383.47 Mn -546.29 Mn - 33.06 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 33.06 Mn
Mar 31, 2026 33.94 Mn
Dec 31, 2025 34.16 Mn
Sep 30, 2025 45.64 Mn
Jun 30, 2025 34.96 Mn
Mar 31, 2025 36.40 Mn
Dec 31, 2024 42.89 Mn
Sep 30, 2024 43.61 Mn
Jun 30, 2024 33.45 Mn
Mar 31, 2024 35.26 Mn
Dec 31, 2023 40.69 Mn
Sep 30, 2023 38.88 Mn
Jun 30, 2023 40.23 Mn
Mar 31, 2023 39.99 Mn
Dec 31, 2022 41.15 Mn
Sep 30, 2022 39.24 Mn
Jun 30, 2022 41.22 Mn
Mar 31, 2022 39.02 Mn
Dec 31, 2021 35.33 Mn
Sep 30, 2021 32.75 Mn
API Access

C4 Therapeutics Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=CCCC&period=max&api_key=YOUR_API_KEY